Found: 13
Select item for more details and to access through your institution.
Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 11, p. 1089, doi. 10.1111/dom.12754
- By:
- Publication type:
- Article
Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 11, p. 1093, doi. 10.1111/dom.12757
- By:
- Publication type:
- Article
Lipid and Carbohydrate Metabolism in IDDM During Moderate and Intense Exercise.
- Published in:
- Diabetes, 1995, v. 44, n. 9, p. 1066, doi. 10.2337/diab.44.9.1066
- By:
- Publication type:
- Article
Decreased platelet phosphoinositide turnover and enhanced platelet activation in IDDM.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Metabolic and Immunologic Effects of Insulin Lispro in Gestational Diabetes.
- Published in:
- Diabetes Care, 1999, v. 22, n. 9, p. 1422, doi. 10.2337/diacare.22.9.1422
- By:
- Publication type:
- Article
Mixing insulin lispro and ultralente insulin.
- Published in:
- 1997
- By:
- Publication type:
- commentary
Latex allergen allergic reactions.
- Published in:
- 1996
- By:
- Publication type:
- letter
Corrected Q-T interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Lower Glucose Variability and Hypoglycemia Measured by Continuous Glucose Monitoring With Novel Long-Acting Insulin LY2605541 Versus Insulin Glargine.
- Published in:
- Diabetes Care, 2014, v. 37, n. 3, p. 659, doi. 10.2337/dc12-2621
- By:
- Publication type:
- Article
Factors That Impact Symptomatic Diabetic Peripheral Neuropathy in Placebo-Administered Patients From Two 1-Year Clinical Trials.
- Published in:
- Diabetes Care, 2007, v. 30, n. 10, p. 2626, doi. 10.2337/dc07-0608
- By:
- Publication type:
- Article
Challenges in Design of Multicenter Trials.
- Published in:
- Diabetes Care, 2007, v. 30, n. 10, p. 2619, doi. 10.2337/dc06-2479
- By:
- Publication type:
- Article
A 6-Month, Randomized, Double-Masked, Placebo-Controlled Study Evaluating the Effects of the Protein Kinase C-β Inhibitor Ruboxistaurin on Skin Microvascular Blood Flow and Other Measures of Diabetic Peripheral Neuropathy.
- Published in:
- Diabetes Care, 2007, v. 30, n. 4, p. 896, doi. 10.2337/dc06-1699
- By:
- Publication type:
- Article